Silverman, Robert H, Nguyen, Carvell, Weight, Christopher J et al. · Nature reviews. Urology · 2010 · DOI
This review examines XMRV, a newly discovered virus that has been found in some people with prostate cancer and some with ME/CFS. Researchers have found the virus at very different rates in different studies (0-27% in prostate cancer, 0-67% in ME/CFS patients). While some antiviral drugs appear to block this virus, scientists still do not know whether XMRV actually causes either disease.
This review is important because it documents early evidence of a potential viral cofactor in ME/CFS at a time when immune dysfunction mechanisms were being actively investigated. Understanding possible retroviral involvement could inform future diagnostic strategies and antiviral treatment approaches, and highlights the need for rigorous etiological research in ME/CFS.
This study does not prove that XMRV causes ME/CFS or prostate cancer. The wide variation in detection rates (0–67% in ME/CFS) across studies suggests methodological differences or contamination issues, and the review itself acknowledges that causality remains unknown. Correlation between viral presence and disease does not establish causation, and subsequent research raised significant questions about the validity of XMRV detection in these populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →